MEDICINOVA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
MEDICINOVA, INC. (MNOV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 512.00 thousand shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2025-08-14
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-06-30 was 60.00K shares, a 74.03% decline year-over-year.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-03-31 was 452.00K shares, a 106.29% increase year-over-year.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2024-12-31 was 1.32M shares, a 152.19% increase year-over-year.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2024-09-30 was 71.80K shares.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 1.84M shares, a 85.54% increase from fiscal 2023.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 992.18K shares, a 71.75% increase from fiscal 2022.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 577.70K shares, a 51.55% increase from fiscal 2021.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2021 was 381.18K shares, a 22.97% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2025-06-30 | 60.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 512.00K shares 10-Q · filed 2025-08-14 | 1.83M shares derived: sum of 3 quarters · filed 2025-08-14 | 1.90M shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 452.00K shares 10-Q · filed 2025-05-13 | 1.77M shares derived: sum of 2 quarters · filed 2025-05-13 | 1.84M shares derived: sum of 3 quarters · filed 2025-05-13 | 2.07M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 1.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | 1.39M shares derived: sum of 2 quarters · filed 2025-02-19 | 1.62M shares derived: sum of 3 quarters · filed 2025-02-19 | 1.84M shares 10-K · filed 2025-02-19 |
| 2024-09-30 | 71.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 302.80K shares derived: sum of 2 quarters · filed 2024-11-13 | 521.90K shares 10-Q · filed 2024-11-13 | 1.04M shares derived: sum of 4 quarters · filed 2025-02-19 |
| 2024-06-30 | 231.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 450.11K shares 10-Q · filed 2024-08-08 | 973.11K shares derived: sum of 3 quarters · filed 2025-02-19 | 973.11K shares derived: sum of 4 quarters · filed 2025-02-19 |
| 2024-03-31 | 219.10K shares 10-Q · filed 2024-05-09 | 742.11K shares derived: sum of 2 quarters · filed 2025-02-19 | 742.11K shares derived: sum of 3 quarters · filed 2025-02-19 | 1.18M shares derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-12-31 | 523.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | 523.00K shares derived: sum of 2 quarters · filed 2025-02-19 | 965.50K shares derived: sum of 3 quarters · filed 2025-02-19 | 992.18K shares 10-K · filed 2025-02-19 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 442.50K shares derived: sum of 2 quarters · filed 2023-11-09 | 469.18K shares 10-Q · filed 2023-11-09 | 469.18K shares derived: sum of 4 quarters · filed 2024-02-15 |
| 2023-06-30 | 442.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 469.18K shares 10-Q · filed 2023-08-09 | 469.18K shares derived: sum of 3 quarters · filed 2024-02-15 | 497.85K shares derived: sum of 4 quarters · filed 2024-02-15 |
| 2023-03-31 | 26.68K shares 10-Q · filed 2023-05-11 | 26.68K shares derived: sum of 2 quarters · filed 2024-02-15 | 55.35K shares derived: sum of 3 quarters · filed 2024-02-15 | 70.68K shares derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 28.67K shares derived: sum of 2 quarters · filed 2024-02-15 | 44.00K shares derived: sum of 3 quarters · filed 2024-02-15 | 577.70K shares 10-K · filed 2024-02-15 |
| 2022-09-30 | 28.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 44.00K shares derived: sum of 2 quarters · filed 2022-11-10 | 577.70K shares 10-Q · filed 2022-11-10 | 687.70K shares derived: sum of 4 quarters · filed 2023-03-28 |
| 2022-06-30 | 15.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 549.03K shares 10-Q · filed 2022-08-11 | 659.03K shares derived: sum of 3 quarters · filed 2023-03-28 | 673.96K shares derived: sum of 4 quarters · filed 2023-03-28 |
| 2022-03-31 | 533.70K shares 10-Q · filed 2022-05-12 | 643.70K shares derived: sum of 2 quarters · filed 2023-03-28 | 658.63K shares derived: sum of 3 quarters · filed 2023-03-28 | 658.63K shares derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-12-31 | 110.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | 124.93K shares derived: sum of 2 quarters · filed 2023-03-28 | 124.93K shares derived: sum of 3 quarters · filed 2023-03-28 | 381.18K shares 10-K/A · filed 2023-03-28 |
| 2021-09-30 | 14.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 14.93K shares derived: sum of 2 quarters · filed 2021-11-12 | 271.18K shares 10-Q · filed 2021-11-12 | 311.18K shares derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 256.25K shares 10-Q · filed 2021-08-12 | 296.25K shares derived: sum of 3 quarters · filed 2022-02-16 | 371.25K shares derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-03-31 | 256.25K shares 10-Q · filed 2021-05-13 | 296.25K shares derived: sum of 2 quarters · filed 2022-02-16 | 371.25K shares derived: sum of 3 quarters · filed 2022-02-16 | 376.25K shares derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-12-31 | 40.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | 115.00K shares derived: sum of 2 quarters · filed 2022-02-16 | 120.00K shares derived: sum of 3 quarters · filed 2022-02-16 | 494.84K shares 10-K · filed 2022-02-16 |
| 2020-09-30 | 75.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | 80.00K shares derived: sum of 2 quarters · filed 2020-10-26 | 454.84K shares 10-Q · filed 2020-10-26 | 454.84K shares derived: sum of 4 quarters · filed 2021-02-19 |
| 2020-06-30 | 5.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | 379.84K shares 10-Q · filed 2020-07-28 | 379.84K shares derived: sum of 3 quarters · filed 2021-02-19 | 401.54K shares derived: sum of 4 quarters · filed 2021-02-19 |
| 2020-03-31 | 374.84K shares 10-Q · filed 2020-04-23 | 374.84K shares derived: sum of 2 quarters · filed 2021-02-19 | 396.54K shares derived: sum of 3 quarters · filed 2021-02-19 | 396.54K shares derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | 21.70K shares derived: sum of 2 quarters · filed 2021-02-19 | 21.70K shares derived: sum of 3 quarters · filed 2021-02-19 | 126.70K shares 10-K · filed 2021-02-19 |
| 2019-09-30 | 21.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-24 | 21.70K shares derived: sum of 2 quarters · filed 2019-10-24 | 126.70K shares 10-Q · filed 2019-10-24 | 126.70K shares derived: sum of 4 quarters · filed 2020-02-13 |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | 105.00K shares 10-Q · filed 2019-07-25 | 105.00K shares derived: sum of 3 quarters · filed 2020-02-13 | 105.00K shares derived: sum of 4 quarters · filed 2020-02-13 |
| 2019-03-31 | 105.00K shares 10-Q · filed 2019-04-25 | 105.00K shares derived: sum of 2 quarters · filed 2020-02-13 | 105.00K shares derived: sum of 3 quarters · filed 2020-02-13 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | 0.00 shares derived: sum of 2 quarters · filed 2020-02-13 | 1.00K shares 10-K · filed 2020-02-13 | |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | 1.00K shares 10-Q · filed 2018-10-25 | ||
| 2018-06-30 | 1.00K shares 10-Q · filed 2018-07-23 | |||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | 2.40K shares derived: sum of 2 quarters · filed 2019-02-13 | 7.40K shares 10-K · filed 2019-02-13 | |
| 2017-09-30 | 2.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-23 | 7.40K shares 10-Q · filed 2017-10-23 | ||
| 2017-06-30 | 5.00K shares 10-Q · filed 2017-07-26 | |||
| 2016-12-31 | 548.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | 626.57K shares derived: sum of 2 quarters · filed 2019-02-13 | 629.57K shares derived: sum of 3 quarters · filed 2019-02-13 | 687.37K shares 10-K · filed 2019-02-13 |
| 2016-09-30 | 78.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-25 | 81.00K shares derived: sum of 2 quarters · filed 2016-10-25 | 138.80K shares 10-Q · filed 2016-10-25 | 138.80K shares derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | 3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-26 | 60.80K shares 10-Q · filed 2016-07-26 | 60.80K shares derived: sum of 3 quarters · filed 2018-02-13 | |
| 2016-03-31 | 57.80K shares 10-Q · filed 2016-04-27 | 57.80K shares derived: sum of 2 quarters · filed 2018-02-13 | ||
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | 3.00K shares 10-K · filed 2018-02-13 | ||
| 2015-09-30 | 3.00K shares 10-Q · filed 2015-10-29 | |||
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2017-02-14 | 2.50K shares derived: sum of 3 quarters · filed 2017-02-14 | 29.82K shares derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | 2.50K shares derived: sum of 2 quarters · filed 2017-02-14 | 29.82K shares derived: sum of 3 quarters · filed 2017-02-14 | 49.07K shares 10-K · filed 2017-02-14 |
| 2014-09-30 | 2.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | 29.82K shares derived: sum of 2 quarters · filed 2014-11-13 | 49.07K shares 10-Q · filed 2014-11-13 | 476.67K shares derived: sum of 4 quarters · filed 2014-11-13 |
| 2014-06-30 | 27.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | 46.58K shares 10-Q · filed 2014-08-13 | 474.17K shares derived: sum of 3 quarters · filed 2014-08-13 | 899.83K shares derived: sum of 4 quarters · filed 2014-08-13 |
| 2014-03-31 | 19.26K shares 10-Q · filed 2014-05-08 | 446.85K shares derived: sum of 2 quarters · filed 2014-05-08 | 872.51K shares derived: sum of 3 quarters · filed 2014-05-08 | 1.58M shares derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-12-31 | 427.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | 853.25K shares derived: sum of 2 quarters · filed 2014-03-27 | 1.56M shares derived: sum of 3 quarters · filed 2014-03-27 | 1.64M shares 10-K · filed 2014-03-27 |
| 2013-09-30 | 425.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | 1.14M shares derived: sum of 2 quarters · filed 2013-11-07 | 1.21M shares 10-Q · filed 2013-11-07 | 2.12M shares derived: sum of 4 quarters · filed 2013-11-07 |
| 2013-06-30 | 710.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 787.23K shares 10-Q · filed 2013-08-08 | 1.69M shares derived: sum of 3 quarters · filed 2013-08-08 | 1.53M shares derived: sum of 4 quarters · filed 2013-08-08 |
| 2013-03-31 | 76.50K shares 10-Q · filed 2013-05-08 | 983.88K shares derived: sum of 2 quarters · filed 2013-05-08 | 819.95K shares derived: sum of 3 quarters · filed 2013-05-08 | |
| 2012-12-31 | 907.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | 743.45K shares derived: sum of 2 quarters · filed 2013-03-28 | 453.69K shares 10-K · filed 2013-03-28 | |
| 2012-09-30 | -163.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -453.69K shares 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | -289.76K shares 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |